LOS ANGELES (KABC) -- The Food and Drug Administration's approval process is one of the most stringent in the world, but now some experts are questioning newer drugs that go through a quicker review.

"We can do better," commissioner says ...

Accelerated approval of semaglutide 7.2 mg establishes a higher-dose, once-weekly GLP-1 RA option for long-term weight reduction under the FDA’s National Priority Voucher framework. STEP UP (n=1407) ...

Food and Drug Administration Commissioner Marty Makary said approving drugs for human consumption is moving at a “record” pace. Makary confirmed that the FDA’s review process will not slow down ...

A commentary by FDA officials Vinay Prasad, MD, MPH, and Martin Makary, MD, MPH, details the new system for drug approvals in the US. FDA Commissioner Martin Makary, MD, MPH, and his top deputy Vinay ...

Orforglipron is the first new molecular entity cleared under the FDA's Commissioner's National Priority Voucher (CNPV) pilot ...

Is CMS Circumventing FDA Drug Approval Standards While Congress Moves to Shut the Hemp Market Down? With Congress tightening federal THC limits and the FDA still evaluating cannabinoid safety ...

A new daily pill to help with weight loss has been approved by the U.S. Food and Drug Administration (FDA), and it moved ...

The agency approved the once-a-day GLP-1 pill for adults with obesity or adults who are overweight with weight-related medical problems.